» Articles » PMID: 3509975

DNA Reactivity and in Vitro Cytotoxicity of the Novel Antitumor Agent 1,5,2,4-dioxadithiepane-2,2,4,4-tetraoxide (NSC-348948) in Human Embryo Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 1986 Apr 1
PMID 3509975
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

1,5,2,4-Dioxadithiepane-2,2,4,4-tetraoxide (cyclic-SoSo) is structurally a novel synthetic compound but may functionally act as an alkylating agent. The effects of cyclic-SoSo on DNA were studied in IMR-90 and VA-13 human embryo cells by means of DNA alkaline elution analysis. In contrast to a number of bifunctional alkylating agents, cyclic-SoSo produced no DNA-DNA interstrand cross-links in either cell line, even at concentration which produced a greater than 3 log cell kill. At equimolar concentrations cyclic-SoSo induced DNA-protein cross-links in both cell lines to a similar extent. Frank DNA breaks and alkali-labile DNA lesions were detected in both cell lines. A greater quantity of strand breaks appeared in the IMR-90 than in the VA-13 cell line after exposure to cyclic-SoSo. However, cyclic-SoSo was more cytotoxic to the VA-13 cell line in vitro than to the IMR-90 cell line. Thus cyclic-SoSo may not be a typical bifunctional alkylating agent in that its mechanism of action does not appear to involve DNA interstrand cross-linking.

Citing Articles

Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.

Dive C, Workman P, Watson J Cancer Chemother Pharmacol. 1989; 25(3):149-55.

PMID: 2557170 DOI: 10.1007/BF00689574.


Testicular endocrine effects of alkane methanesulphonates related to the Leydig cell cytotoxic compound, EDS.

Edwards G, Jackson H, Morris I Cancer Chemother Pharmacol. 1990; 26(1):19-25.

PMID: 2157553 DOI: 10.1007/BF02940288.